Method for cleaving a target RNA using a Cas6 polypeptide
View Patent ↗Provided herein are methods for cleaving a target RNA polynucleotide. The target RNA polynucleotide includes a Cas6 recognition domain and a cleavage site, and may be based on a repeat from a CRISPR locus. The methods may be practiced in vivo or in vitro. Also provided are polypeptides that have Cas6 endoribonuclease activity in the presence of a target RNA polynucleotide, and methods for using the polypeptides.
1. A method for cleaving a target RNA polynucleotide sequence comprising:
incubating an isolated target RNA polynucleotide with an isolated wild-type Cas6 (CRISPR-associated 6) polypeptide under conditions suitable for cleavage of the target RNA polynucleotide to thereby cleave the target RNA polynucleotide,
wherein the target RNA polynucleotide comprises a wild-type CRISPR (Clustered regularly interspaced short palindromic repeats) locus repeat present in a wild-type prokaryotic genome, and wherein the repeat comprises a recognition domain and a cleavage site for the wild-type Cas6 polypeptide;
wherein the wild-type Cas6 polypeptide is encoded by said wild-type prokaryotic genome and has Cas6 endoribonuclease activity, wherein the wild-type Cas6 polypeptide comprises a catalytic triad of tyrosine, histidine, and lysine, at residues corresponding to Tyr31, His46, and Lys52, respectively, of SEQ ID NO: 2, and comprises a GhGxxxxxGhG (SEQ ID NO: 190) motif wherein h is a hydrophobic amino acid, and wherein x is any amino acid; and
wherein the wild-type Cas6 polypeptide cleaves the target RNA polynucleotide at the cleavage site of the CRISPR locus repeat, and wherein the cleavage site is located 5 to 20 nucleotides downstream of the recognition domain for the wild-type Cas6 polypeptide.
2. The method of claim 1 wherein the incubating is at a temperature of 37° C. or 70° C.
3. The method of claim 1 wherein the target RNA polynucleotide comprises the nucleotide sequence of GUUACAAUAAGACUAAAAUAGA↓AUUGAAAG (SEQ ID NO: 238), wherein the arrow refers to the cleavage site for the wild-type Cash polypeptide.
4. A method for cleaving a target RNA polynucleotide comprising:
incubating an isolated target RNA polynucleotide with an isolated Cas6 polypeptide under conditions suitable for cleavage of the target RNA polynucleotide to thereby cleave the target RNA polynucleotide,
wherein the target RNA polynucleotide comprises the nucleotide sequence of 5′-NUUACAAUAAGACCN 1 N↓N-3′ (SEQ ID NO: 242), wherein N 1 is 7 nucleotides, wherein the arrow refers to a cleavage site for said isolated Cas6 polypeptide, wherein N is any nucleotide, wherein one or both of the nucleotides flanking the cleavage site is A, wherein the target RNA polynucleotide comprises a recognition domain for said isolated Cas6 polypeptide, and wherein the target RNA polynucleotide is cleaved by a Cas6 polypeptide comprising the amino acid sequence of SEQ ID NO:2; and
wherein the isolated Cas6 polypeptide comprises an amino acid sequence having at least 85% sequence identity with the amino acid sequence of SEQ ID NO: 2, has Cas6 endoribonuclease activity, and cleaves a target RNA polynucleotide comprising the nucleotide sequence of SEQ ID NO: 238, wherein the isolated Cas6 polypeptide comprises a catalytic triad of tyrosine, histidine, and lysine, at residues corresponding to Tyr31, His46, and Lys52, respectively, of the amino acid sequence of SEQ ID NO:2, and comprises a GhGxxxxxGhG (SEQ ID NO: 190) motif wherein h is a hydrophobic amino acid, and wherein x is any amino acid.
5. The method of claim 4 wherein the recognition domain for said isolated Cas6 polypeptide comprises the nucleotide sequence of 5′-GTTACAATAAGA-3′ (SEQ ID NO: 237), wherein each thymidine of the recognition domain, or the complement thereof, is replaced with a uridine.
6. The method of claim 4 wherein the incubating is at a temperature of 37° C. or 70° C.
7. A method for cleaving a target RNA polynucleotide sequence comprising:
incubating a genetically modified microbe comprising a target RNA polynucleotide and a wild-type Cas6 polypeptide under conditions suitable for cleavage of the target RNA polynucleotide to thereby cleave the target RNA polynucleotide,
wherein the genetically modified microbe comprises an exogenous polynucleotide encoding the target RNA polynucleotide or a polynucleotide encoding the wild-type Cas6 polypeptide,
wherein the target RNA polynucleotide comprises a wild-type CRISPR locus repeat present in a wild-type prokaryotic genome, and wherein the repeat comprises a recognition domain and a cleavage site for the wild-type Cas6 polypeptide;
wherein the wild-type Cas6 polypeptide is encoded by said wild-type prokaryotic genome and has Cas6 endoribonuclease activity, wherein the wild-type Cas6 polypeptide comprises a catalytic triad of tyrosine, histidine, and lysine, at residues corresponding to Tyr31, His46, and Lys52, respectively, of SEQ ID NO: 2, and comprises a GhGxxxxxGhG (SEQ ID NO: 190) motif wherein h is a hydrophobic amino acid, and wherein x is any amino acid; and
wherein the wild-type Cas6 polypeptide cleaves the target RNA polynucleotide at the cleavage site of the CRISPR locus repeat, and wherein the cleavage site is located 5 to 20 nucleotides downstream of the recognition domain for the wild-type Cas6 polypeptide.
8. The method of claim 1 wherein the amino acids xxxxx of the GhGxxxxxGhG (SEQ ID NO: 190) motif comprise at least one lysine or arginine.
9. The method of claim 4 wherein the amino acids xxxxx of the GhGxxxxxGhG (SEQ ID NO: 190) motif comprise at least one lysine or arginine.
10. The method of claim 7 wherein the amino acids xxxxx of the GhGxxxxxGhG (SEQ ID NO: 190) motif comprise at least one lysine or arginine.
11. The method of claim 1 wherein the recognition domain for the wild-type Cas6 polypeptide is located within the first 5 to 15 nucleotides of the CRISPR locus repeat.